Advertisement
Home Blog Page 2796
The number of people affected by blindness and visual impairment is increasing

Review: Global Prevalence of Blindness, Visual Impairment Up

0
Increase seen despite drop in age-standardized prevalence of blindness, impairment from 1990-2015
Occupational exposures to vapors

Occupational Exposures Linked to Interstitial Lung Disease

0
Job exposure matrix score increase in vapors, gas, dust, fumes exposure ups high attenuation areas
Antibiotic prophylaxis can prevent recurrence of cellulitis

Review: Antibiotics Effectively Prevent Recurrent Cellulitis

0
Protective effects of antibiotics for recurrence, incidence don't last after prophylaxis is stopped
Characteristics unrelated to allograft quality are associated with later acceptance in the deceased donor kidney match-run

Factors Unrelated to Allograft Quality Tied to Organ Turndown

0
Holiday or weekend procurement, shorter donor stature, location of procurement tied to later acceptance
For women with preexisting cardiovascular disease or three or more coronary risk factors

No Effect of B Vitamin on Fracture Risk in Women at High CV Risk

0
No reduction in fracture risk or impact on change in markers of bone turnover for women at high CV risk
There is overall good agreement between two-dimensional and three-dimensional magnetic resonance imaging techniques to measure the thoracic aorta and main pulmonary artery

2D and 3D MRI Techniques Similar for Cardiac Measures

0
Findings to establish range of normal measures for thoracic aorta, pulmonary artery
Developmental polybrominated diphenyl ethers exposure may be tied to reduced intelligence

Exposure to Flame Retardants May Lower IQ in Children

0
Findings based on review, meta-analysis assessing developmental exposure in children
An exercise and nutrition intervention is feasible for patients with head and neck cancer during or after radiotherapy

Intervention May Cut Muscle Loss From RT for Head & Neck Cancer

0
Resistance training and nutrition intervention may offset loss of muscle mass secondary to side effects

FDA Approves Mavyret for Hepatitis C

0
Combo drug is first approved therapy for hepatitis C to require as few as eight weeks of treatment

Seven Imaging Biomarkers Tied to Cognition in Male Fighters

0
Areas under the curve of 0.76 and 0.69 at baseline and follow-up with optimized classifier